| No. | Publications |
|
1 |
Atiya, N., Gunn, C. L. Q., Lim, B. W. W., Ser, G. T. Z., Mahendran, H., Ong, J. B. S. Q., ... & Wong, C. K. (2023). PATTERNS AND TRENDS IN FIRST-LINE ANTI-TUBERCULOSIS DRUG RESISTANCE IN A MAJOR MALAYSIAN TERTIARY TEACHING HOSPITAL OVER A 4-YEAR PERIOD (2017-2020). International Journal of Infectious Diseases, 134, S17. |
|
2 |
Balakrishnan, V., Ramanathan, G., Zhou, S., & Wong, C. K. (2023). Optimized support vector regression predicting treatment duration among tuberculosis patients in Malaysia. Multimedia Tools and Applications, 1-14. |
|
3 |
Chai, C. S., Ng, D. L. C., Bt Mos, S., Ibrahim, M. A. B., Tan, S. B., Pang, Y. K., & Liam, C. K. (2023). COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV1–a post-hoc analysis of pooled data. BMC Pulmonary Medicine, 23(1), 1-9. |
|
4 |
Chan, S. C., Beh, H. C., Nathan, J. J., Sahadeevan, Y., Engkasan, J. P., Chuah, S. Y., ... & RESPIRE Collaborators. (2023). Pulmonary rehabilitation capacity building through a teach-the-teacher programme: A Malaysian experience. Journal of Global Health, 13. |
|
5 |
Cho, B. C., Ahn, M. J., Kang, J. H., Soo, R. A., Reungwetwattana, T., Chih-Hsin Yang, J., ... & Zaric, B. (2023). Lazertinib Versus Gefitinib as First-line Treatment in Patients With EGFR-mutated Advanced Non-Small Cell Lung Cancer (NSCLC): Results From LASER301. Journal of Clinical Oncology, 10-1200. |
|
6 |
Hussein, N., Liew, S. M., Hanafi, N. S., Lee, P. Y., Cheong, A. T., Ghazali, S. S., ... & RESPIRE Collaborators. (2023). Asthma control and care among six public health clinic attenders in Malaysia: A cross‐sectional study. Health Science Reports, 6(5), e1021. |
|
7 |
Kee, Y. S., Wong, C. K., Abdul Aziz, M. A., Zakaria, M. I., Mohd Shaarif, F., Ng, K. S., ... & Khoo, E. M. (2023). 30-Day Readmission Rate of Patients with COPD and Its Associated Factors: A Retrospective Cohort Study from a Tertiary Care Hospital. International Journal of Chronic Obstructive Pulmonary Disease, 2623-2631. |
|
8 |
Lam, D. C. L., Liam, C. K., Andarini, S., Park, S., Tan, D. S., Singh, N., ... & Yang, P. C. (2023). Lung Cancer Screening in Asia: An Expert Consensus Report. Journal of Thoracic Oncology. |
|
9 |
Li, Z., & Lu, S. (2023). Third-Generation EGFR Tyrosine Kinase Inhibitor for Central Nervous System Metastases EGFR-Mutant NSCLC: Current Evidence and Future Perspectives. Journal of Thoracic Oncology, 18(12), 1625-1628. |
|
10 |
Liam, C. K., Ahmad, A. R., Hsia, T. C., Zhou, J., Kim, D. W., Soo, R. A., ... & Wu, Y. L. (2023). Randomized Trial of Tepotinib Plus Gefitinib Versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis. Clinical Cancer Research, 29(10), 1879-1886. |
|
11 |
Liam, C. K., Yew, C. Y., Pang, Y. K., Wong, C. K., Poh, M. E., Tan, J. L., ... & Ibrahim, N. H. (2023). Common driver mutations and programmed death-ligand 1 expression in advanced non-small cell lung cancer in smokers and never smokers. BMC cancer, 23(1), 659. |
|
12 |
Merbouh, M., El Kaouini, A., Aftiss, F. Z., Berrajaa, S., Bkiyer, H., Abda, N., & Housni, B. (2021). Dexamethasone or methylprednisolone therapy in covid-19 pneumonia: a retrospective and comparative study of 513 cases. Annals of Medicine and Surgery, 70, 102858. |
|
13 |
Narayana, J. K., Mac Aogáin, M., Ivan, F. X., Jaggi, T., Keir, H. R., Dicker, A., ... & Chotirmall, S. H. (2023). Topological Data Analysis Reveals Antimicrobial Resistotypes Associated to the Microbiome in Bronchiectasis: An International Multi-centre Study. In A106. MICROBIOME RESEARCH (pp. A2652-A2652). American Thoracic Society. |
|
14 |
Ninomiya, K., Arimura, H., Tanaka, K., Chan, W. Y., Kabata, Y., Mizuno, S., ... & Ng, K. H. (2023). Three-dimensional topological radiogenomics of epidermal growth factor receptor Del19 and L858R mutation subtypes on computed tomography images of lung cancer patients. Computer Methods and Programs in Biomedicine, 236, 107544. |
|
15 |
OHara, R., Liam, C. K., Ahmad, A. R., Hsia, T. C., Zhou, J., Kim, D. W., ... & Wu, Y. L. (2023). PPD02. 02 Tepotinib+ Gefitinib in Patients with EGFR-Mutant NSCLC with MET Amplification (METamp): Final Analysis of INSIGHT. Journal of Thoracic Oncology, 18(3), e6-e7. |
|
16 |
Poh, M. E., How, S. H., Ho, G. F., Pang, Y. K., Hasbullah, H. H., Tho, L. M., ... & Zainal Abidin, M. A. (2023). Real-World Treatment and Outcomes of ALK-Positive Metastatic Non–Small Cell Lung Cancer in a Southeast Asian Country. Cancer Management and Research, 31-41. |
|
17 |
Sia, L. C., Pang, Y. K., Wong, C. K., Soo, C. I., Ibrahim, N. H., Munusamy, V., ... & Liam, C. K. (2023). Symptomatic prolonged viral shedding in long COVID-Our experience with remdesivir. |
|
18 |
Soo, C. I., Sia, L. C., Munusamy, V., Ibrahim, N. H., Chin, K. K., Loh, T. C., ... & Liam, C. K. (2023). Tissue coagulum clot cellblock from EBUS-TBNA for the diagnosis of necrotic lung and mediastinal lesions. |
|
19 |
Thng, K. X., Mac Aogáin, M., Ivan, F. X., Narayana, J. K., Jaggi, T. K., Keir, H. R., ... & Chotirmall, S. H. (2023). The plasmidome in bronchiectasis. |
|
20 |
Tiew, P. Y., Narayana, J. K., Quek, M. S. L., Ang, Y. Y., San Ko, F. W., Poh, M. E., ... & Chotirmall, S. H. (2023). Sensitisation to recombinant Aspergillus fumigatus allergens and clinical outcomes in COPD. European Respiratory Journal, 61(1). |
|
21 |
Wong, C. K., Ng, K. S., Choo, S. Q. R., Lee, C. J., Teo, Y. P., Liew, S. M., ... & Chiang, D. M. (2023). Factors associated with all-cause mortality in tuberculosis patients in a Malaysian tertiary hospital. The Journal of Infection in Developing Countries, 17(08), 1138-1145. |
| No. | Publications |
|
1 |
Agarwal, D., Hanafi, N. S., Khoo, E. M., Parker, R. A., Ghorpade, D., Salvi, S., ... & PAUL, B. (2022). Burden of chronic respiratory diseases in population in four South/South-East Asian low-and middle-income countries (LMICs). |
|
2 |
Ahn, M. J., Cho, B. C., Pang, Y. K., Voon, P. J., Kim, S. W., Carpeno, J. D. C., ... & Piotrowska, Z. (2022). LBA12 Tumour genomics in patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib in the phase II ELIOS study. Annals of Oncology, 33, S1563-S1564. |
|
3 |
Ayakannu, R., Abdullah, N. A., Raj, V. L., Radhakrishnan, A. K., & Liam, C. K. (2022). Clinical characteristics, cytokine profiles and plasma IgE in adults with asthma. Molecular Immunology, 143, 50-57. |
|
4 |
Chai, C. S., Mos, S. B., Ibrahim, M. A. B., Tan, S. B., Pang, Y. K., & Liam, C. K. (2022). Exacerbation Frequency, COPD Symptoms, and Health-Related Quality of Life of COPD Patients According to Post-Bronchodilator FEV1–A Post-hoc Analysis of Pooled Data from Two Cross-Sectional Studies. |
|
5 |
Chan, S. C., Engkasan, J. P., Nathan, J. J., Sekhon, J. K., Hussein, N., Suhaimi, A., ... & Khoo, E. M. (2022). Home-Pulmonary Rehabilitation Programme for Patients with Chronic Respiratory Diseases in Malaysia: A Mixed Method Feasibility Study. Loh, T. C., Pang, Y. K., Liam, C. K., Chew, M. F., & Tan, J. L. (2022). |
|
6 |
Cheah, C. W., Al-Maleki, A. R., Vaithilingam, R. D., Vadivelu, J., Sockalingam, S., Baharuddin, N. A., & Bartold, P. M. (2022). Associations between inflammation-related LL-37 with subgingival microbial dysbiosis in rheumatoid arthritis patients. Clinical Oral Investigations, 26(5), 4161-4172. |
|
7 |
Cho, B. C., Ahn, M. J., Kang, J. H., Soo, R., Baisamut, T., Yang, J. H., ... & Zaric, B. (2022). LBA7 A randomized, double-blind, multinational phase III study to assess the efficacy and safety of lazertinib versus gefitinib in the first-line treatment of patients with EGFR mutation (EGFRm), advanced NSCLC (LASER301; NCT04248829). Annals of Oncology, 33, S1560. |
|
8 |
Chong, Y. M., Chan, Y. F., Jamaluddin, M. F. H., Hasan, M. S., Pang, Y. K., Ponnampalavanar, S., ... & Sam, I. C. (2022). Rhinovirus/enterovirus was the most common respiratory virus detected in adults with severe acute respiratory infections pre-COVID-19 in Kuala Lumpur, Malaysia. PloS one, 17(9), e0273697. |
|
9 |
Connelly, K., Kandane‐Rathnayake, R., Hoi, A., Louthrenoo, W., Hamijoyo, L., Luo, S. F., ... & Morand, E. F. (2022). Association of Modified Systemic Lupus Erythematosus Responder Index Attainment and Long‐Term Clinical Outcomes: A Five‐Year Prospective Study. Arthritis & Rheumatology. |
|
10 |
How, S. H., Liam, C. K., Abidin, M. A. Z., Hasbullah, H. H., Tho, L. M., Ho, G. F., ... & Poh, M. E. (2022). Outcomes of Patients with EGFR-Mutant Advanced NSCLC in a Developing Country in Southeast Asia. Cancer Management and Research, 14, 1995. |
|
11 |
How, S. H., Tho, L. M., Liam, C. K., Hasbullah, H. H., Ho, G. F., Muhammad Nor, I., ... & Soon, S. Y. (2022). Programmed death‐ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non‐small‐cell lung cancer in a resource‐limited country. Thoracic Cancer. |
|
12 |
Itchins, M., Liam, C. K., Ahmad, A., Hsia, T. C., Zhou, J., Kim, D. W., ... & Wu, Y. L. (2022, November). Tepotinib plus gefitinib in patients with EGFR-mutant NSCLC with MET amplification: Final analysis of INSIGHT. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (Vol. 18, pp. 82-83). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY. |
|
13 |
Kandane-Rathnayake, R., Louthrenoo, W., Hoi, A., Luo, S. F., Wu, Y. J. J., Chen, Y. H., ... & Morand, E. F. (2022). ‘Not at target’: prevalence and consequences of inadequate disease control in systemic lupus erythematosus—a multinational observational cohort study. Arthritis research & therapy, 24(1), 1-10. |
|
14 |
Kho, S. S., Soo, C. I., Nasaruddin, M. Z., Ngan, K. W., & Abdul Rahaman, J. A. (2022). Multimodal linear endobronchial ultrasound guided mediastinal lymph node biopsy in the diagnosis of isolated mediastinal lymphadenopathy. Proceedings of Singapore Healthcare, 31, 20101058221111655. |
|
15 |
LIAM, C. K., YEW, C. Y., PANG, Y. K., WONG, C. K., POH, M. E., TAN, J. L., ... & IBRAHIM, N. H. (2022). Common driver mutations and programmed death-ligand 1 expression in advanced non-small cell lung cancer in smokers and never smokers. |
|
16 |
Loh, T. C., Pang, Y. K., Liam, C. K., Chew, M. F., & Tan, J. L. (2022). Metastatic pulmonary calcification mimicking pulmonary tuberculosis: A case report. Respirology Case Reports, 10(10), e01030. |
|
17 |
Mac Aogáin, M., Ivan, F. X., Jaggi, T., Keir, H. R., Dicker, A. J., Hou, A. L. Y., ... & Chotirmall, S. H. (2022). The antimicrobial resistome in bronchiectasis: an international multicentre study. |
|
18 |
Metastatic pulmonary calcification mimicking pulmonary tuberculosis: A case report. Respirology Case Reports, 10(10), e01030. |
|
19 |
Narayana, J. K., Tiew, P. Y., Ang, Y. Y., Quek, M. S. L., Ko, F. W., Lim, A. Y. H., ... & Chotirmall, S. H. (2022). Topological Data Analysis (TDA) of Allergic Sensitization in Bronchiectasis and COPD. In B21. BASIC, CLINICAL, AND TRANSLATIONAL COPD STUDIES: THE ONGOING HUNT FOR UNDERLYING MECHANISMS AND THERAPEUTIC TARGETS (pp. A2402-A2402). American Thoracic Society. |
|
20 |
Ong, P. S., Nur-Aida-Sabrina, M. R., Haziqah-Itqan, A., Lau, S., Mollyza, M. Z., Azmillah, R., ... & Too, C. L. (2022). Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients in Malaysia. The Egyptian Rheumatologist, 44(4), 357-360. |
|
21 |
Piao, M., Ma, X., Tankere, P., Liam, C., Li, J., & Wang, J. (2022). Anlotinib combined with chemotherapy and immunotherapy for advanced pulmonary sarcomatoid cancer: a case report and literature review. Annals of Translational Medicine, 10(18). |
|
22 |
Piotrowska, Z., Ahn, M. J., Pang, Y. K., How, S. H., Sang-We, K., Voon, P. J., ... & Cho, B. C. (2022). 360P ELIOS: A multicentre, molecular profiling study of patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib. Annals of Oncology, 33, S1581-S1582. |
|
23 |
Sam, I. C., Chong, Y. M., Abdullah, A., Fu, J. Y. L., Hasan, M. S., Jamaluddin, F. H., ... & Chan, Y. F. (2022). Changing predominant SARS‐CoV‐2 lineages drives successive COVID‐19 waves in Malaysia, February 2020 to March 2021. Journal of medical virology, 94(3), 1146-1153. |
|
24 |
Sazlina, S. G., Lee, P. Y., Cheong, A. T., Hussein, N., Pinnock, H., Salim, H., ... & Khoo, E. M. (2022). Feasibility of supported self-management with a pictorial action plan to improve asthma control. NPJ primary care respiratory medicine, 32(1), 1-9. |
|
25 |
Sia, L. C., Wong, C. K., Ooi, N. Z. M., Chan, W. Y., Pang, Y., Liam, C. K., ... & Munusamy, V. (2022). Persistent respiratory failure in severe COVID-19 patients-A tertiary centre experience in Kuala Lumpur, Malaysia. |
|
26 |
Tiew, P. Y., Lim, A. Y. H., Keir, H. R., Dicker, A. J., Mac Aogáin, M., Pang, S. L., ... & Chotirmall, S. H. (2022). High frequency of allergic bronchopulmonary Aspergillosis in bronchiectasis-COPD overlap. Chest, 161(1), 40-53. |
|
27 |
Tiew, P. Y., Narayana, J. K., Quek, M. S. L., Ang, Y. Y., Ko, F. W. S., Poh, M. E., ... & Chotirmall, S. H. (2022). Aspergillus sensitization as a treatable trait in COPD.. |
|
28 |
Tiew, P. Y., Narayana, J. K., Quek, M. S. L., Ang, Y. Y., San Ko, F. W., Poh, M. E., ... & Chotirmall, S. H. (2022). Sensitisation to recombinant Aspergillus fumigatus allergens and clinical outcomes in COPD. European Respiratory Journal. |
|
29 |
Wong, C. K., Sia, L. C., Ooi, N. Z. M., Chan, W. Y., & Pang, Y. K. (2022). Severe COVID-19 with persistent respiratory failure—A retrospective cohort study in a tertiary centre in Malaysia. Plos one, 17(11), e0276848. |
|
30 |
Zhang, C., Wang, C., Yang, Z., Bai, Y., Shukuya, T., Poh, M. E., ... & Deng, S. (2022). Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance. Translational Lung Cancer Research, 11(5), 786. |
| No. | Publications |
|
1 |
Lu, S., Shih, J. Y., Jang, T. W., Liam, C. K., & Yu, Y. (2021). Afatinib as first-line treatment in Asian patients with EGFR mutation-positive NSCLC: a narrative review of real-world evidence. Advances in therapy, 38(5), 2038-2053. |
|
2 |
Ninomiya, K., Arimura, H., Chan, W. Y., Tanaka, K., Mizuno, S., Muhammad Gowdh, N. F., ... & Ng, K. H. (2021). Robust radiogenomics approach to the identification of EGFR mutations among patients with NSCLC from three different countries using topologically invariant Betti numbers. PloS one, 16(1), e0244354. |
|
3 |
Poh, M. E., Sundari Ampikaipakan, C. K. L., Chai, C. S., Ramanaidoo, D., & Mydin, H. H. (2021). Management of Asthma Exacerbations in Southeast Asian Tertiary Care. Journal of Asthma and Allergy, 14, 629. |
|
4 |
Liam, C. K., Lee, P., Yu, C. J., Bai, C., & Yasufuku, K. (2021). The diagnosis of lung cancer in the era of interventional pulmonology. The International Journal of Tuberculosis and Lung Disease, 25(1), 6-15. |
|
5 |
Chong, Y. M., Chan, Y. F., Jamaluddin, M. F. H., Hasan, M. S., Pang, Y. K., Ponnampalavanar, S., ... & Sam, I. C. (2021). Detection of respiratory viruses in adults with suspected COVID-19 in Kuala Lumpur, Malaysia. Journal of Clinical Virology, 145, 105000. |
|
6 |
Koh, W. M., Abu Bakar, A. I., Hussein, N., Pinnock, H., Liew, S. M., Hanafi, N. S., ... & Khoo, E. M. (2021). Sociocultural influences on asthma self‐management in a multicultural society: A qualitative study amongst Malaysian adults. Health Expectations, 24(6), 2078-2086. |
|
7 |
Pang, Y. K., Ismail, A. I., Chan, Y. F., Cheong, A., Chong, Y. M., Doshi, P., ... & Taurel, A. F. (2021). Influenza in Malaysian adult patients hospitalized with community-acquired pneumonia, acute exacerbation of chronic obstructive pulmonary disease or asthma: a multicenter, active surveillance study. BMC infectious diseases, 21(1), 1-14. |
|
8 |
Cheong, A. T., Lee, P. Y., Shariff-Ghazali, S., Salim, H., Hussein, N., Ramli, R., ... & Khoo, E. M. (2021). Implementing asthma management guidelines in public primary care clinics in Malaysia. NPJ primary care respiratory medicine, 31(1), 1-8. |
|
9 |
Cheong, A. T., Lee, P. Y., Sazlina, S. G., Salim, H., Hussein, N., Ramli, R., ... & Khoo, E. M. (2021). Meeting the challenges of asthma management guidelines in public primary care clinics in Malaysia: a qualitative study. |
|
10 |
Agarwal, D., Chippagiri, S., Brakema, E., Pinnock, H., Khoo, E. M., Sheikh, A., ... & Juvekar, S. (2021). Chronic obstructive pulmonary disease (COPD) prevalence surveys in low-and middle-income countries (LMICs): A systematic scoping review of methodologies. |
|
11 |
Liew, S. M., Khoo, E. M., Pinnock, H., Mccarthy, S., Lim, Z. N., Pang, Y. K., ... & Sheikh, A. (2021). Exploring the provision of supportive care for people with severe, potentially life limiting chronic obstructive pulmonary disease in Malaysia: a qualitative study. |
|
12 |
Ghazali, S. S., Lee, P. Y., Cheong, A. T., Salim, H. S., Hussein, N., Pinnock, H., ... & Khoo, E. M. (2021). A pictorial asthma action plan to improve asthma control in Malaysian adults. |
|
13 |
Agarwal, D., Hanafi, N. S., Khoo, E. M., Parker, R., Ghorpade, D., Salvi, S., ... & Pinnock, H. (2021). Predictors for detecting chronic respiratory diseases in population surveys: a pilot study for RESPIRE 4CCORD study. |
|
14 |
Hussein, N., Ramli, R., Ishak, I., Ho, B. K., Isa, S. M., Aman, Z., ... & Sheikh, A. (2021). Assessment of asthma control and associated risk factors: findings from the Klang Asthma Cohort Study in Malaysia. |
|
15 |
Hussein, N., Liew, S. M., Hanafi, N. S., Khoo, E. M., Pinnock, H., Pang, Y. K., ... & Sheikh, A. (2021). Primary care management of asthma–findings from the Klang Asthma Cohort Study in Malaysia. |
|
16 |
Lee, P. Y., Cheong, A. T., Ghazali, S. S., Salim, H., Wong, J., Hussein, N., ... & Khoo, E. M. (2021). Barriers to implementing asthma self-management in Malaysian primary care: qualitative study exploring the perspectives of healthcare professionals. NPJ primary care respiratory medicine, 31(1), 1-8. |
|
17 |
Park, K., Jӓnne, P. A., Kim, D. W., Han, J. Y., Wu, M. F., Lee, J. S., ... & Noh, Y. S. (2021). Olmutinib in T790M‐positive non–small cell lung cancer after failure of first‐line epidermal growth factor receptor‐tyrosine kinase inhibitor therapy: A global, phase 2 study. Cancer, 127(9), 1407-1416. |
|
18 |
Chan, S. C., Sekhon, J. K., Engkasan, J. P., Nathan, J. J., Mirza, F. T., Liew, S. M., ... & RESPIRE Collaborators. (2021). Barriers and challenges of implementing pulmonary rehabilitation in Malaysia: Stakeholders’ perspectives. Journal of Global Health, 11. |
|
19 |
Hanafi, N. S., Agarwal, D., Chippagiri, S., Brakema, E. A., Pinnock, H., Sheikh, A., ... & Khoo, E. M. (2021). Chronic respiratory disease surveys in adults in low-and middle-income countries: A systematic scoping review of methodological approaches and outcomes. Journal of global health, 11. |
|
20 |
Mac Aogáin, M., Narayana, J. K., Tiew, P. Y., Ali, N., Yong, V. F. L., Jaggi, T. K., ... & Chotirmall, S. H. (2021). Integrative microbiomics in bronchiectasis exacerbations. Nature Medicine, 27(4), 688-699. |
|
21 |
Tiew, P. Y., Dicker, A. J., Keir, H. R., Poh, M. E., Pang, S. L., Mac Aogáin, M., ... & Chotirmall, S. H. (2021). A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD. European Respiratory Journal, 57(3). |
|
22 |
Tian, Y., Li, P., Xiao, Z., Zhou, J., Xue, X., Jiang, N., ... & Zhao, X. (2021). Triptolide inhibits epithelial-mesenchymal transition phenotype through the p70S6k/GSK3/β-catenin signaling pathway in taxol-resistant human lung adenocarcinoma. Translational lung cancer research, 10(2), 1007. |
| No. | Publications |
|
1 |
Chong, Y. M., Sam, I. C., Ponnampalavanar, S., Omar, S. F. S., Kamarulzaman, A., Munusamy, V., ... & Teh, C. S. J. (2020). Complete Genome Sequences of SARS-CoV-2 Strains Detected in Malaysia. Microbiology Resource Announcements, 9(20). |
|
2 |
Chong, Y. M., Sam, I. C., Chong, J., Bador, M. K., Ponnampalavanar, S., Omar, S. F. S., ... & Chan, Y. F. (2020). SARS-CoV-2 lineage B. 6 is the major contributor to transmission in Malaysia. bioRxiv. |
|
3 |
Rajadurai, P., How, S. H., Liam, C. K., Sachithanandan, A., Soon, S. Y., & Tho, L. M. (2020). Lung Cancer in Malaysia. Journal of Thoracic Oncology, 15(3), 317-323. |
|
4 |
Liam, C. K., Liam, Y. S., Poh, M. E., & Wong, C. K. (2020). Accuracy of lung cancer staging in the multidisciplinary team setting. Translational Lung Cancer Research, 9(4), 1654. |
|
5 |
Chai, C. S., Liam, C. K., Poh, M. E., Ong, D. B., Pang, Y. K., Cheah, P. L., Ho, G. F., & Alip, A. (2020). Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors. Cancer management and research, 12, 5439–5450. https://doi.org/10.2147/CMAR.S253760 |
|
6 |
Liam, C. K., Liam, Y. S., & Wong, C. K. (2020). Extracellular vesicle-based EGFR genotyping in bronchoalveolar lavage fluid. Translational lung cancer research, 9(2), 168–171. https://doi.org/10.21037/tlcr.2020.03.06 |
|
7 |
Liam, C. K., Mallawathantri, S., & Fong, K. M. (2020). Is tissue still the issue in detecting molecular alterations in lung cancer?. Respirology. |
|
8 |
Liam, C. K., Stone, E., Andarini, S., Liam, Y. S., Lam, D. C., & Lee, P. (2020). Molecular testing of metastatic non-small cell lung cancer in the Asia-Pacific region. Respirology (Carlton, Vic.), 25(7), 685–687. |
|
9 |
Chai, C. S., & Liam, C. K. (2020). Common concerns in managing bronchial asthma during the COVID-19 pandemic. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 24(7), 750–752. |
|
10 |
Chai, C. S., Mos, S. B., Su, A. T., Ibrahim, M. A. B., Musa, A. N. B., Tan, S. B., ... & Liam, C. K. (2020). Clinical phenotypes and heath-related quality of life of COPD patients in a rural setting in Malaysia–a cross-sectional study. BMC pulmonary medicine, 20(1), 1-9. |
|
11 |
Wu, Y. L., Cheng, Y., Zhou, J., Lu, S., Zhang, Y., Zhao, J., ... & Chen, Y. M. (2020). Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial. The Lancet Respiratory Medicine. |
|
12 |
Subakir, H., Chong, Y. M., Chan, Y. F., Hasan, M. S., Jamaluddin, M. F. H., Pang, Y. K., ... & Sam, I. C. (2020). Selective media and real-time PCR improves diagnosis of melioidosis in community-acquired pneumonia in a low-incidence setting in Kuala Lumpur, Malaysia. Journal of Medical Microbiology, 69(1), 49-51. |
|
13 |
Tiew, P. Y., San Ko, F. W., Narayana, J. K., Poh, M. E., Xu, H., Neo, H. Y., ... & Kamaruddin, N. H. (2020). ‘High risk’clinical and inflammatory clusters in COPD of Chinese descent. Chest. |
|
14 |
POH, M. E., AMPIKAIPAKAN, S., LIAM, C. K., CHAI, C. S., RAMANAIDOO, D., & MYDIN, H. H. (2020). Management of Acute Asthma in Southeast Asian Tertiary Care. |
|
15 |
Tiew, P. Y., San Ko, F. W., Pang, S. L., Matta, S. A., Sio, Y. Y., Poh, M. E., ... & Gaultier, N. E. (2020). Environmental fungal sensitisation associates with poorer clinical outcomes in COPD. European Respiratory Journal. |
|
16 |
Tiew, P. Y., Dicker, A. J., Keir, H. R., Poh, M. E., Pang, S. L., Mac Aogáin, M., ... & Tee, A. (2020). A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD. European Respiratory Journal. |
| No. | Publications |
|
1 |
Poh, M. E., Liam, C. K., Mun, K. S., Chai, C. S., Wong, C. K., Tan, J. L., ... & Chin, K. K. (2019). Epithelial‐to‐mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy. Thoracic cancer, 10(9), 1841-1845. |
|
2 |
Liam, C. K. (2019). Tumour mutation burden of non‐small cell lung cancer with pre‐existing ILD. Respirology. |
|
3 |
Ho GF, Chai CS, Alip A, Wahid MI, Abdullah MM, Foo YC, How SH, Zaatar A, Lam KS, Leong KW, Yusof MM. Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study. BMC cancer. 2019 Dec 1;19(1):896. |
|
4 |
Buder, A., Hochmair, M. J., Setinek, U., & Filipits, M. (2019). 495P Tracking of activating EGFR mutations predicts progression-free survival in advanced EGFR-mutated NSCLC patients treated with osimertinib. Annals of Oncology, 30(Supplement_9), mdz437-021. |
|
5 |
Chai, C. S., Liam, C. K., Lin, O. P., Pang, Y. K., Ho, G. F., Alip, A., ... & Tan, J. L. (2019). Afatinib versus gefitinib or erlotinib in first-line setting for Malaysia patients with EGFR mutant advanced lung adenocarcinoma. Annals of Oncology, 30, ix164. |
|
6 |
Chai, C. S., Po Lin, O., Liam, C. K., Pang, Y. K., Ho, G. F., Alip, A., ... & Tan, J. L. (2019). 494P Comparison of pattern of disease progression and prevalence of acquired T790M mutation in Malaysia patients with EGFR mutant lung adenocarcinoma upon failure of first-line afatinib, gefitinib and erlotinib. Annals of Oncology, 30(Supplement_9), mdz437-020. |
|
7 |
Liam, C. K., Stone, E., & Andarini, S. (2019). P1. 14-02 Survey of EGFR Molecular Testing of NSCLC in the Asia-Pacific Region. Journal of Thoracic Oncology, 14(10), S552. |
|
8 |
Kato, Y., Hosomi, Y., Watanabe, K., Yomota, M., Kawai, S., Okuma, Y., ... & Okamura, T. (2019). Impact of clinical features on the efficacy of osimertinib therapy in patients with T790M-positive non-small cell lung cancer and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors. Journal of thoracic disease, 11(6), 2350. |
|
9 |
Rajadurai, P., Cheah, P. L., How, S. H., Liam, C. K., Annuar, M. A. A., Omar, N., ... & Tho, L. M. (2019). Molecular testing for advanced non-small cell lung cancer in Malaysia: Consensus statement from the College of Pathologists, Academy of Medicine Malaysia, the Malaysian Thoracic Society, and the Malaysian Oncological Society. Lung Cancer. |
|
10 |
Wong, T. H., Tan, T. H., George, U. R., Kow, K. S., & Liam, C. K. (2019). Application of 18F-FDG PET-CT in the management of pulmonary nodule and mass-a pictorial review. The Medical journal of Malaysia, 74(3), 250-256. |
|
11 |
Mok, T. S., Wu, Y. L., Kudaba, I., Kowalski, D. M., Cho, B. C., Turna, H. Z., ... & Kubota, K. (2019). Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial. The Lancet, 393(10183), 1819-1830. |
|
12 |
Ayakannu, R., Abdullah, N. A., Radhakrishnan, A. K., Raj, V. L., & Liam, C. K. (2019). Relationship between various cytokines implicated in asthma. Human immunology. |
|
13 |
Tan, S. B., Liam, C. K., Pang, Y. K., Ng, D. L. C., Wong, T. S., Khoo, K. W. S., ... & Chai, C. S. (2019). The Effect of 20-Minute Mindful Breathing on the Rapid Reduction of Dyspnea at Rest in Patients With Lung Diseases: A Randomized Controlled Trial. Journal of pain and symptom management, 57(4), 802-808. |
|
14 |
Liam, C. K. (2019). The role of osimertinib in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer. Journal of thoracic disease, 11(Suppl 3), S448. |
|
15 |
Liam, C. K. (2019). Central nervous system activity of first-line osimertinib in epidermal growth factor receptor-mutant advanced non-small cell lung cancer. Annals of translational medicine, 7(3). |
|
16 |
Gray JE, Okamoto I, Sriuranpong V, Vansteenkiste JF, Imamura F, Lee JS, Pang YK, Cobo M, Kasahara K, Cheng Y, Nogami N. Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib vs Comparator EGFR-TKI as First-Line Treatment in Patients with EGFR Mutated Advanced NSCLC. Clinical Cancer Research. 2019 Jan 1. |
|
17 |
Gray, J. E., Okamoto, I., Sriuranpong, V., Vansteenkiste, J., Imamura, F., Lee, J. S., ... & Nogami, N. (2019). Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non–Small Cell Lung Cancer. Clinical Cancer Research, 25(22), 6644-6652. |
|
18 |
Liew, S. M., Khoo, E. M., Pinnock, H., Mccarthy, S., Lim, Z. N., Pang, Y. K., ... & Sheikh, A. (2019). Interviewing the breathless COPD participant. |
|
19 |
Subakir, H., Chong, Y. M., Chan, Y. F., Hasan, M. S., Jamaluddin, M. F. H., Pang, Y. K., ... & Sam, I. C. (2019). Selective media and real-time PCR improves diagnosis of melioidosis in community-acquired pneumonia in a low-incidence setting in Kuala Lumpur, Malaysia. Journal of medical microbiology, jmm001108. |
|
20 |
Koh, W. M., Khoo, E. M., Bakar, A. I. A., Hussein, N., Pinnock, H., Liew, S. M., ... & Salbiah, M. I. (2019). Asthma patients’ views and experiences of self-management in Malaysia: a qualitative study. |
|
21 |
Tan, S. B., Liam, C. K., Pang, Y. K., Ng, D. L. C., Wong, T. S., Khoo, K. W. S., ... & Chai, C. S. (2019). The Effect of 20-Minute Mindful Breathing on the Rapid Reduction of Dyspnea at Rest in Patients With Lung Diseases: A Randomized Controlled Trial. Journal of pain and symptom management, 57(4), 802-808. |
|
22 |
Liam, C. K., Chai, C. S., Poh, M. E., Ong, D. B. L., Cheah, P. L., Pang, Y. K., ... & Alip, A. (2019). EP1. 14-17 Acquired T790M Mutation in Patients Failing Treatment with First or Second-Generation EGFR-Tyrosine Kinase Inhibitors. Journal of Thoracic Oncology, 14(10), S1038. |
|
23 |
yee Tiew, P., San Ko, F. W., Xu, H., Poh, M. E., Narayana, J. K., Sim, G. J. H., ... & Kamaruddin, N. H. (2019). Chronic Obstructive Pulmonary Disease (COPD) in patients of Chinese ethnicity reveal clinically relevant phenotypes. |
Last Update: 05/11/2024